Eli Lilly (Mexico) Today

LLY Stock  MXN 12,919  43.05  0.33%   

Performance

14 of 100

 
Low
 
High
Good

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Eli Lilly is trading at 12918.90 as of the 29th of March 2024; that is -0.33 percent down since the beginning of the trading day. The stock's open price was 12961.95. Eli Lilly has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for Eli Lilly And are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of April 2022 and ending today, the 29th of March 2024. Click here to learn more.
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. ELI LILLY operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. The company has 950.18 M outstanding shares. More on Eli Lilly And

Moving together with Eli Stock

  0.67MRK Merck CompanyPairCorr

Moving against Eli Stock

  0.9GILD Gilead SciencesPairCorr
  0.84ROGN Roche Holding AGPairCorr
  0.73BIIB Biogen IncPairCorr
  0.51SNYN SanofiPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Eli Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eli Lilly's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eli Lilly or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman, CEO and PresJohn Lechleiter
Business ConcentrationDrug Manufacturers - Major, Healthcare (View all Sectors)
Eli Lilly And (LLY) is traded on Mexican Exchange in Mexico and employs 47 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 6.16 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Eli Lilly's market, we take the total number of its shares issued and multiply it by Eli Lilly's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Eli Lilly And operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 950.18 M outstanding shares. Eli Lilly And has accumulated about 2.2 B in cash with 7.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.39.
Check Eli Lilly Probability Of Bankruptcy
Ownership Allocation
Eli Lilly holds a total of 950.18 Million outstanding shares. The majority of Eli Lilly And outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Eli Lilly And to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Eli Lilly. Please pay attention to any change in the institutional holdings of Eli Lilly And as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Eli Ownership Details

Eli Lilly And Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Eli Lilly market risk premium is the additional return an investor will receive from holding Eli Lilly long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eli Lilly. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Eli Lilly's alpha and beta are two of the key measurements used to evaluate Eli Lilly's performance over the market, the standard measures of volatility play an important role as well.

Eli Stock Against Markets

Picking the right benchmark for Eli Lilly stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Eli Lilly stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Eli Lilly is critical whether you are bullish or bearish towards Eli Lilly And at a given time. Please also check how Eli Lilly's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eli Lilly without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

Eli Lilly Corporate Directors

Eli Lilly corporate directors refer to members of an Eli Lilly board of directors. The board of directors generally takes responsibility for the Eli Lilly's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Eli Lilly's board members must vote for the resolution. The Eli Lilly board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Ellen MarramLead Independent DirectorProfile
Kathi SeifertIndependent DirectorProfile
Ralph AlvarezIndependent DirectorProfile
Jamere JacksonIndependent DirectorProfile

How to buy Eli Stock?

Before investing in Eli Lilly, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Eli Lilly. To buy Eli Lilly stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Eli Lilly. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Eli Lilly stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Eli Lilly And stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Eli Lilly And stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Eli Lilly And, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Eli Stock please use our How to Invest in Eli Lilly guide.

Already Invested in Eli Lilly And?

The danger of trading Eli Lilly And is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Eli Lilly is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Eli Lilly. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Eli Lilly And is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
CEOs Directory
Screen CEOs from public companies around the world
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.